Cancer Blog
- Dr. Robert Nagourney -

Dr. Robert A. Nagourney, MD

“New” Immune Therapy Active in Late-Stage Cancer Patients

Here in 2023, we suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.

Dr. Robert A. Nagourney, MD

A Year-End Reflection

2022 Reflection. Among our most important accomplishments in 2022 was the installation of a world-class Mass Spectrometry research program.

Dr. Robert A. Nagourney, MD

IN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOU

Despite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.

Dr. Robert A. Nagourney, MD

SEVEN WITH ONE BLOW: OVERCOMING THE ODDS IN CANCER

Those who have read my blogs know that I apply the EVA/PCD laboratory method to select treatments and combinations. This grants me a higher

Dr. Robert A. Nagourney, MD

IN ADVANCED CANCER, QUALITY NOT JUST QUANTITY OF LIFE MATTERS

With the explosion of new cancer drugs, combinations, targeted agents, and immune therapies, one question remains: What is the impact of...